Assembly Biosciences, Inc. (ASMB)
20.13
-0.73
(-3.50%)
USD |
NASDAQ |
Oct 30, 16:00
20.19
+0.06
(+0.30%)
After-Hours: 20:00
Assembly Biosciences Market Cap : 399.59M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 399.59M |
| October 29, 2026 | 414.08M |
| October 28, 2026 | 408.32M |
| October 27, 2026 | 402.96M |
| October 26, 2026 | 390.46M |
| October 23, 2026 | 393.83M |
| October 22, 2026 | 402.56M |
| October 21, 2026 | 406.14M |
| October 20, 2026 | 420.63M |
| October 19, 2026 | 400.18M |
| October 16, 2026 | 398.79M |
| October 15, 2026 | 408.32M |
| October 14, 2026 | 407.53M |
| October 13, 2026 | 403.76M |
| October 12, 2026 | 451.99M |
| October 09, 2026 | 467.08M |
| October 08, 2026 | 452.98M |
| October 07, 2026 | 455.56M |
| October 06, 2026 | 440.28M |
| October 05, 2026 | 451.40M |
| October 02, 2026 | 447.43M |
| October 01, 2026 | 456.16M |
| September 30, 2026 | 466.28M |
| September 29, 2026 | 466.08M |
| September 28, 2026 | 468.67M |
| Date | Value |
|---|---|
| September 25, 2026 | 469.86M |
| September 24, 2026 | 469.66M |
| September 23, 2026 | 475.81M |
| September 22, 2026 | 505.19M |
| September 21, 2026 | 504.99M |
| September 18, 2026 | 495.66M |
| September 17, 2026 | 503.01M |
| September 16, 2026 | 505.79M |
| September 15, 2026 | 518.29M |
| September 14, 2026 | 574.86M |
| September 11, 2026 | 591.54M |
| September 10, 2026 | 604.64M |
| September 09, 2026 | 652.48M |
| September 08, 2026 | 700.32M |
| September 04, 2026 | 726.52M |
| September 03, 2026 | 717.19M |
| September 02, 2026 | 728.90M |
| September 01, 2026 | 698.33M |
| August 31, 2026 | 667.57M |
| August 28, 2026 | 676.30M |
| August 27, 2026 | 690.79M |
| August 26, 2026 | 703.10M |
| August 25, 2026 | 701.31M |
| August 24, 2026 | 700.32M |
| August 21, 2026 | 682.45M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 211.81B |
| BridgeBio Pharma, Inc. | 14.64B |
| ACADIA Pharmaceuticals, Inc. | 3.544B |
| Alnylam Pharmaceuticals, Inc. | 22.09B |
| Anika Therapeutics, Inc. | 280.37M |
Market Cap Related Metrics
| PS Ratio | 4.323 |
| Price to Book Value | 1.307 |
| Price | 20.13 |
| Earnings Yield | -0.37% |